BMP7 upregulation and ACVR1 signaling are not only observed in the in vitro and in vivo study results after PRC2 inhibition (Figures 2 and 3), but also correlates with better clinical survival outcomes in DLBCL patients (Figure 7). This evidence concerns the gene ACVR1 and diffuse large B-cell lymphoma.